WASHINGTON, July 18, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the second quarter 2019. For the quarter ended June 28, 2019, net earnings were $731.3 million, or $0.97 per diluted share which represents a 2.0% year-over-year increase from

SECAUCUS, N.J., July 18, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the expansion of the Global Diagnostics Network (GDN), a strategic working group of major diagnostic laboratories collaborating to generate enhanced diagnostics insights to improve the delivery of global health

SALT LAKE CITY, July 18, 2019 /PRNewswire/ -- Empiric Health, a tech-enabled service company with leading edge solutions used to identify unwarranted clinical variation announced that Alycia Parker has joined as Vice President of Marketing.  In her role, Alycia will be responsible for marketing strategy and planning, sales operations a

WASHINGTON, July 18, 2019 /PRNewswire/ -- The Leapfrog Group, an independent national health care watchdog organization, today released

SAN JOSE, Calif., July 18, 2019 /PRNewswire/ -- Del Grande Dealer Group (DGDG.com), the Bay Area's largest family-owned automotive group, recently partnered with the Subaru Loves To Care prog

MALMÖ, Sweden, July 18, 2019 /PRNewswire/ -- Imlifidase benefits highlighted in recent ATC presentations. Expansion outside transplantation with initiation of study in Guillain-Barré Syndrome (GBS) continues.Highlights for the second quarter 2019- At the 2019 American Transplant Congress (ATC), Dr. Edmund Hu

STOCKHOLM, July 18, 2019 /PRNewswire/ -- JANUARY 1 – JUNE 30, 2019 (compared with the corresponding period a year ago)Net sales increased 8.6% to SEK 62,724m (57,741) Organic net sales increased 4.1% Organic net sa

STOCKHOLM, July 18, 2019 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announces that new data related to BAN2401 were presented on July 17. The presentations were held by BioArctic and its partner, Eisai, at the Alzheimer's Association International Conference® 2019 (AAIC®) in Los Angeles

NEW YORK, July 17, 2019 /PRNewswire/ -- Phreesia, Inc. ("Phreesia"), a leading patient intake management platform, today announced the pricing of its initial public offering of 9,288,194 shares of common stock at a public offering price of $18.00 per share, before underwriting discounts, consisting of 7,812,500 shares to be issued and s

NANJING, China, July 17, 2019 /PRNewswire/ -- GenScript Biotech Corp., one of the leading Biologics contract development and manufacturing organizations (CDMOs) in China, today announced that its Biologics research and development (R&D)